Welcome to our dedicated page for CATL news (Ticker: CATL), a resource for investors and traders seeking the latest updates and insights on CATL stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CATL's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CATL's position in the market.
Catalyst Acquisition Corp. (Nasdaq: CATLU/CATL) priced its initial public offering of 20,000,000 units at $10.00 per unit, for gross proceeds of approximately $200 million. The units are expected to begin trading on Nasdaq under the symbol CATLU on July 28, 2026.
Each unit includes one Class A ordinary share and one right to receive one-seventh of one Class A ordinary share upon consummation of an initial business combination. The Class A shares and rights are expected to trade separately no later than the 52nd day after pricing, under symbols CATL and CATLR, respectively. Santander is sole book-running manager, and the underwriter has a 45-day option to purchase up to 3,000,000 additional units at the IPO price to cover over-allotments. According to Catalyst, the offering is expected to close on July 29, 2026, subject to customary closing conditions.